Role of Perforator Flaps in Back Defects Reconstruction
Launched by ASSIUT UNIVERSITY · May 6, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a type of surgery called "perforator flaps," which are used to repair back defects in children born with a condition called myelomeningocele. Myelomeningocele is a type of spina bifida, where the spine does not close properly, leading to a defect in the back. The study aims to compare two different surgical methods: one using just perforator flaps and the other using a combination of perforator and additional flaps.
The trial is open to children aged between 2 months and 1 year who have moderate to large defects on their back, specifically those measuring between 25 and 39 square centimeters. Unfortunately, children with larger defects, other types of myelomeningocele, or certain health issues won't be able to participate. If eligible, participants can expect to undergo surgery as part of the study and will be closely monitored to see how well each method works in repairing their back. The study is currently not recruiting patients, but it is an important step toward improving surgical options for children with this condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • infants up to one year,
- • dorso-lumbar myelomeningocele.
- • moderate to large myelomeningocele defects. (25 - 39 cm2 ) .
- Exclusion Criteria:
- • cervical myelomeningocele
- • very large defects (more than 40 cm2 )
- • preterm newborn patients.
- • hematological disease
- • any problem against prone position of the patient
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
mahmoud Abdelaal, doctor
Study Director
professor
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported